Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overviewAll 13F holders of DNLIFull Q2 2026 holdings

Shares (Q2 2026)
24,466
Value
$629.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of DNLI by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202624,466$629.3K<0.1%−3,271−11.8%ReducedHolders
Q1 202627,737$532.5K<0.1%−2,945−9.6%ReducedHolders
Q4 202530,682$506.6K<0.1%+2,827+10.1%AddedHolders
Q3 202527,855$404.5K<0.1%−4,727−14.5%ReducedHolders
Q2 202532,582$455.8K<0.1%−879−2.6%ReducedHolders
Q1 202533,461$454.9K<0.1%−8,364−20.0%ReducedHolders
Q4 202441,825$852.4K<0.1%+9,877+30.9%AddedHolders
Q3 202431,948$930.6K<0.1%+7,150+28.8%AddedHolders
Q2 202424,798$575.8K<0.1%−6,407−20.5%ReducedHolders
Q1 202431,205$640.3K<0.1%+2,820+9.9%AddedHolders
Q4 202328,385$609.1K<0.1%+4,053+16.7%AddedHolders
Q3 202324,332$502.0K<0.1%+109+0.4%AddedHolders
Q2 202324,223$714.8K<0.1%+1,937+8.7%AddedHolders
Q1 202322,286$513.5K<0.1%−4,622−17.2%ReducedHolders
Q4 202226,908$748.3K<0.1%+4,119+18.1%AddedHolders
Q3 202222,789$700.0K<0.1%+615+2.8%AddedHolders
Q2 202222,174$653.0K<0.1%−9,707−30.4%ReducedHolders
Q1 202231,881$1.03M<0.1%−7,521−19.1%ReducedHolders
Q4 202139,402$1.76M<0.1%−435−1.1%ReducedHolders
Q3 202139,837$2.01M<0.1%−5,525−12.2%ReducedHolders
Q2 202145,362$3.56M<0.1%+11,785+35.1%AddedHolders
Q1 202133,577$1.92M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.